Skip to navigation Skip to content



About this Medication
  • Brand Name: Mayzent®
  • Chemical Name: Siponimod
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in tablet form.


Mayzent® is an immune system-modulating therapy thought to act by retaining certain white blood cells in the body's lymph nodes, keeping them out of circulation and out of the central nervous system.  Mayzent® also enters the central nervous system (brain and spinal cord) where it may have direct anti-inflammatory and/or other effects.

Mayzent® is approved by the FDA for relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).

Click here to read the Prescribing Information for healthcare providers and scroll to page 22 for the medication guide for patients. 


The Mayzent® Patient Support Program

Financial Assistance Program

Alongside MS™


Your input is important!

We believe that people affected by MS live better lives when they're connected.  To help us provide you with the best resources, support and information, please provide your feedback in a short survey.
Take the survey